EWTX
Edgewise Therapeutics, Inc. · Healthcare
CFO R Michael Carruthers sold $3.6M of Edgewise Therapeutics, Inc.
Sold$3,573,980
$28.57Price
125,092Shares
−95%Stake
What EWTX did after the filing
- The stock from Wed, Sep 25 open, $25.23
- +45.1%
- S&P 500, same days
- +3.5%
Measured over 30 trading days, to the Nov 6 close.
Traded Fri, Sep 20. Filed Tue, Sep 24, 4:22 PM ET, after the close. Returns use the Sep 25 open and the Nov 6 close. Not investment advice.